CSF Biochemistries, Glucose Metabolism, and Diurnal Activity Rhythms in Alcoholic, Violent Offenders, Fire Setters, and Healthy Volunteers

Archives of General Psychiatry

Volumn 51, Issue 1, 1994, Pages 20-27

  Virkkunen, Matti ^a   Rawlings, Robert ^b   Tokola, Riitta ^a   Poland, Russell E ^c   Guidotti, Alessandro ^d   Nemeroff, Charles ^e   Bissette, Garth ^f   Kalogeras, Konstantine ^g   Karonen, Sirkka Liisa ^a   Linnoila, Markku ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Division of Biological Psychiatry Harbor UCLA Medical Center ^*  (United States)

^e EMORY UNIVERSITY   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ASPARTAME; GLUCOSE;

ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARSON; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PHYSICAL ACTIVITY; SEROTONIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; VIOLENCE;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOLISM; ANTISOCIAL PERSONALITY DISORDER; CIRCADIAN RHYTHM; FIRESETTING BEHAVIOR; FORENSIC PSYCHIATRY; GLUCOSE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; IMPULSE CONTROL DISORDERS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MOTOR ACTIVITY; SEROTONIN; TESTOSTERONE; VIOLENCE;

EID: 0028053207     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1994.03950010020003     Document Type: Article

References (47)

1. Roy A, Virkkunen M, Linnoila M. Serotonin in suicide, violence, and alcoholism. In: Coccaro E, Murphy D, eds. Serotonin in Major Psychiatric Disorders. Washington, DC: American Psychiatric Association; 1991: 187–208.
2. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci- 1983;33: 2609–2614.
3. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. Cerebrospinal fluid monoamine metabolites in male arsonists. Arch Gen Psychiatry. 1987;44: 241–247.
4. Roy A, Virkkunen M, Guthrie S, Linnoila M. Indices of serotonin and glucose metabolism in violent offenders, arsonists and alcoholics. In: Mann JJ, Stanley M, eds. Psychobiology of Suicidal Behavior. New York, NY: New York Academy of Science; 1986: 202–220.
5. Linnoila M, Virkkunen M, Roy A. Biochemical aspects of aggression in man. In: Bunney WE Jr, Costa E, Potkin SG, eds. Clinical Neuropharmacology. New York, NY: Raven Press; 1986;(suppl 1): 377–379.
6. Palkovits M, Saavedra JM, Jacobovits DM, Kizer JS, Zaborsky L, Brownstein MJ. Serotonergic innervation of the forebrain: effects of lesions on serotonin and tryptophan hydroxylase levels. Brain Res. 1977;130: 121–134.
7. Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 1972;42: 201–206.
8. Yamamoto H, Nagai K, Nagakava H. Additional evidence that the suprachiasmatic nucleus is the center for regulation of insulin secretion and glucose homeostasis. Brain Res. 1984;304: 237–241.
9. Virkkunen M, DeJong J, Bartko J, Goodwin FK, Linnoila M. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters: a follow-up study. Arch Gen Psychiatry. 1989;46: 600–603.
10. Virkkunen M, DeJong J, Bartko J, Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch Gen Psychiatry. 1989;46: 604–606.
11. Linnoila M, DeJong J, Virkkunen M. Family history of alcoholism in violent offenders and impulsive fire setters. Arch Gen Psychiatry. 1989;46: 679–681.
12. Roy A, Virkkunen M, Guthrie S, Poland R, Linnoila M. Monoamines, glucose metabolism, suicidal and aggressive behaviors. Psychopharmacol Bull. 1986;22: 661–665.
13. Virkkunen M. Urinary free cortisol secretion in habitually violent offenders. Acta Psychiatr Scand. 1985;72: 40–44.
14. Spitzer R, Endicott J. Schedule of Affective Disorders and Schizophrenia—Lifetime Version. Third Edition. New York, NY: New York State Psychiatric Institute; 1978.
15. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
16. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
17. Scheinin M, Chang W-H, Kirk K, Linnoila M. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high performance liquid chromatography using electrochemical detection. Anal Biochem. 1983;131: 246–253.
18. Barbaccia M, Costa E, Ferrero P, Guidotti A, Roy A, Sunderland T, Pickar D, Paul S, Goodwin FK. Diazepam binding inhibitor: a brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia and Alzheimer's disease. Arch Gen Psychiatry. 1986;43: 1143–1147.
19. Smith MA, Bissette G, Slotkin TA, Kwight DL, Nemeroff CB. Release of corticotropin releasing factor from rat brain regions in vitro. Endocrinology. 1986;118: 1997–2001.
20. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive compulsive disorder. Arch Gen Psychiatry. 1992;49: 9–20.
21. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ Jr, May C, Post RM, Chrousos GP, Gold PW. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab. 1991;72: 260–271.
22. Rahe RH, Karson S, Howard NS Jr, Rubin RT, Poland RE. Psychological and physiological assessments on American Hostages freed from captivity in Iran. Psychosom Med. 1990;52: 1–16.
23. Wehr TA, Wirz-Justice A, Goodwin FK, Breitmeir J, Craig C. 48 hour sleepwake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry. 1982;39: 559–565.
24. BMDP Statistical Software Manual. Los Angeles: University of California Press; 1990.
25. Cotter LB, Helzer JE, Mager D, Spitznagel EM, Compton WM. Agreement between DSM-III and-III-R substance use disorders. Drug Alcohol Depend. 1991;29: 17–25.
26. Morin LP, Blanchard J. Depletion of brain serotonin by 5,7-DHT modifies hamster circadian rhythm response to light. Brain Res. 1991;566: 173–185.
27. Porrino LJ, Rapoport JL, Behar D, Sceery W, lsmond DR, Bunney WE Jr. A naturalistic assessment of motor activity of hyperactive boys. Arch Gen Psychiatry. 1983;40: 681–687.
28. Virkkunen M. Reactive hypoglycemic tendency among habitually violent offenders. Nutr Rev. 1986;44(suppl): 94–103.
29. Brewerton RD, Berrettini WH, Nurnberger JI, Linnoila M. Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls: findings with 5-HIAA and HVA. Psychiatry Res. 1988;23: 257–265.
30. Roy A, Adinoff B, Linnoila M. Cerebrospinal fluid variables among alcoholics lack seasonal variation. Acta Psychiatr Scand. 1991;24: 187–194.
31. Soubrie P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci. 1986;9: 319–364.
32. Stanley M, Traskman-Benz L, Dorovini-Zis K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci. 1985;37: 1279–1286.
33. Miller LA. Impulsivity, risk-taking, and the ability to synthesize fragmented information after frontal lobectomy. Neuropsychologia. 1992;30: 69–79.
34. Agren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ. Interacting neurotransmitter systems: a non-experimental approach to the 5-HIAA-HVA correlation in human CSF. Psychiatry Res. 1986;20: 175–193.
35. Ellsworth JD, Leahy DJ, Roth RH Jr, Redmond D Jr. Homovanillic acid concentration in brain, CSF and plasma as indicators of central dopamine function in primates. J Neural Transm. 1987;68: 51–62.
36. Weinberger D, Berman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry. 1988;45: 609–615.
37. Roy A, Pickar D, DeJong J, Karoum F, Linnoila M. Suicidal behavior in depression: relationship to noradrenergic function. Biol Psychiatry. 1989;25: 341–350.
38. Higley JD, Mehlman PT, Taub DM, Higley SB, Suomi SJ, Vickers D, Linnoila M. Cerebrospinal fluid monoamine and adrenal correlates of aggression in freeranging rhesus monkeys. Arch Gen Psychiatry. 1992;49: 436–441.
39. Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever LJ. Growth hormone responses to intravenous clonidine challenge correlate with behavior irrtability in psychiatric patients and healthy volunteers. Psychiatry Res. 1991;39: 129–139.
40. Steiger A, von Bardeleben V, Wiedeman K, Holsboer F. Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J Psychiatr Res. 1991;25: 169–177.
41. Mason JW, Giller EL, Kosten TR. Serum testosterone differences between patients with schizophrenia and those with affective disorder. Biol Psychiatry. 1991;82: 1–28.
42. Archer J. The influence of testosterone on human aggression. Br J Psychol. 1991;82: 1–28.
43. Ehrenkranz J, Bliss E, Sheard MH. Plasma testosterone: correlation with aggressive behavior and social dominance in man. Psychosom Med. 1976;36: 469–475.
44. Dabbs JM Jr, Frady RL, Carr TS, Besh NF. Saliva testosterone and criminal violence in young adult prison inmates. Psychosom Med. 1987;49: 174–182.
45. Sapolsky RM, Plotsky PM. Hypercortisolism and its possible neural bases. Biol Psychiatry. 1990;27: 937–952.
46. Berrettini WH, Nurnberger JI Jr, Zerbe RL, Gold PW, Chrousos GP, Tomai T. CSF neuropeptides in euthymic bipolar patients and controls. Br J Psychiatry. 1987;150: 208–212.
47. De Wied D, Jolles J. Neuropeptides derived from proopiocortin: behavioral, physiological and neurochemical effects. Physiol Rev. 1982;62: 976–1059.